Acid-Base Fundamentals in Physiology

Acid-base chemistry governs countless physiological processes that sustain life. The human body maintains a remarkably narrow blood pH range of 7.35 to 7.45, a condition essential for proper enzyme function, oxygen transport, and cellular metabolism. This balance is achieved through three primary systems: chemical buffers, the respiratory system, and the renal system. The bicarbonate buffer system, represented by the Henderson‑Hasselbalch equation (pH = pKa + log [HCO₃⁻] / [H₂CO₃]), is the most important extracellular buffer. Proteins and phosphates serve as additional buffers in intracellular and renal environments.

The lungs adjust pH quickly by retaining or expelling CO₂ through changes in respiration rate. The kidneys respond more slowly but provide long‑term regulation by excreting hydrogen ions and reabsorbing bicarbonate. Understanding these mechanisms is critical for clinicians managing acid‑base disorders. For a deeper dive into the Henderson‑Hasselbalch equation, see LibreTexts on the Henderson‑Hasselbalch Equation.

Acid‑Base Disorders in Clinical Medicine

Respiratory Acidosis and Alkalosis

Respiratory acidosis occurs when hypoventilation leads to CO₂ retention, shifting the bicarbonate‑carbonic acid equilibrium toward acidity. Hypoventilation can stem from chronic obstructive pulmonary disease (COPD), opioid overdose, severe pneumonia, or neuromuscular disorders such as Guillain‑Barré syndrome. The initial response is cellular buffering, followed by renal compensation that retains bicarbonate and excretes hydrogen ions over one to two days. In severe cases, noninvasive positive‑pressure ventilation or intubation may be needed to correct the underlying ventilatory failure.

Respiratory alkalosis results from hyperventilation, which expels CO₂ too rapidly, raising blood pH above 7.45. Common triggers include anxiety attacks, fever, high altitude, pulmonary embolism, or liver disease. The renal compensatory response involves decreasing bicarbonate reabsorption and excreting more bicarbonate in urine. Treatment focuses on addressing the underlying cause; for anxiety‑driven hyperventilation, rebreathing into a paper bag can help, though this practice is controversial and should be used cautiously.

Metabolic Acidosis and Alkalosis

Metabolic acidosis arises from a primary decrease in serum bicarbonate. This can result from excessive acid production (e.g., diabetic ketoacidosis, lactic acidosis), loss of bicarbonate (e.g., diarrhea, renal tubular acidosis), or ingestion of acids (e.g., salicylate overdose). The anion gap calculation — using Na+ – (Cl− + HCO₃⁻) — helps differentiate between high‑anion‑gap and normal‑anion‑gap metabolic acidosis, guiding further diagnostic workup. Respiratory compensation occurs via hyperventilation (Kussmaul respirations), lowering pCO₂ to counteract the acidosis.

Metabolic alkalosis is driven by an excess of bicarbonate or loss of hydrogen ions, often from vomiting, nasogastric suction, diuretic use, or excessive mineralocorticoid activity. The body attempts respiratory compensation by hypoventilating, which raises pCO₂. Saline‑responsive metabolic alkalosis (e.g., from vomiting) typically corrects with volume expansion, while saline‑unresponsive forms (e.g., from hyperaldosteronism) require targeted therapy. Blood gas analysis provides the pH, pCO₂, and bicarbonate levels needed to diagnose the specific disorder and guide treatment.

External resource: Blood Gas Testing – National Heart, Lung, and Blood Institute

Pharmacological Applications of Acid‑Base Chemistry

pH‑Dependent Drug Absorption and Ion Trapping

The absorption, distribution, and excretion of many drugs depend on their ionization state, which is determined by the drug’s pKa and the pH of the surrounding environment. This principle, known as the pH‑partition hypothesis, explains why weak acids (e.g., aspirin, pKa 3.5) are best absorbed in the acidic stomach, while weak bases (e.g., propranolol, pKa 9.5) are better absorbed in the more alkaline small intestine. Ion trapping occurs when a drug becomes ionized in a compartment and cannot diffuse back across a membrane; this concept is exploited in the treatment of drug overdoses. For example, alkalinizing the urine with sodium bicarbonate traps weak acids like phenobarbital, promoting their renal elimination. Conversely, acidifying urine with ammonium chloride can enhance elimination of weak bases such as amphetamine. The same principle is used to enhance bioavailability of certain drugs — for instance, the weakly basic oral antifungal ketoconazole requires an acidic gastric pH for optimal dissolution, so patients are advised to avoid antacids and proton‑pump inhibitors.

Design of pH‑Sensitive Drug Delivery Systems

Many oral medications are formulated with enteric coatings that resist dissolution in the acidic stomach and release the active ingredient only in the higher‑pH environment of the small intestine. This protects acid‑labile drugs (e.g., omeprazole) and reduces gastric irritation. Similarly, pH‑responsive hydrogels and nanoparticle carriers are being developed to target the colonic pH for treating inflammatory bowel disease (IBD) or colon cancer. A promising approach is the use of poly(methacrylic acid)‑based nanoparticles that swell at the colonic pH (around 7) to release encapsulated drugs such as budesonide. In cancer therapy, the slightly acidic tumor microenvironment (pH 6.5–6.9 compared to normal tissue pH ~7.4) can be exploited to trigger drug release from pH‑sensitive liposomes or polymer‑drug conjugates, enhancing local cytotoxicity while reducing systemic toxicity.

Therapeutic Agents That Modulate pH

Antacids

Antacids are over‑the‑counter preparations containing weakly basic compounds such as magnesium hydroxide (Mg(OH)₂), calcium carbonate (CaCO₃), or aluminum hydroxide (Al(OH)₃). They neutralize hydrochloric acid in the stomach, providing rapid relief from heartburn and gastroesophageal reflux disease (GERD). Each antacid has distinct properties: magnesium‑based products can cause diarrhea, while aluminum‑based ones may cause constipation. Combination products like magnesium‑aluminum hydroxide (e.g., Maalox, Mylanta) balance these side effects and also contain simethicone to reduce gas. Calcium carbonate is potent and also serves as a calcium supplement, but may cause rebound acid hypersecretion. Long‑term use of high‑dose antacids can lead to metabolic alkalosis, especially in patients with renal impairment.

Acid‑Reducing Medications

Two major classes of acid‑reducing drugs target gastric acid secretion directly. Histamine‑2 (H₂) receptor antagonists, such as ranitidine and famotidine, compete with histamine on parietal cells to reduce acid output. They have a rapid onset and are useful for nocturnal acid breakthrough. Proton pump inhibitors (PPIs), including omeprazole, esomeprazole, and lansoprazole, irreversibly inhibit the H⁺/K⁺‑ATPase (proton pump) in gastric parietal cells. Because PPIs are prodrugs that require activation in an acidic environment, they are formulated as delayed‑release capsules or granules. These agents are cornerstones in the management of peptic ulcer disease, GERD, and Zollinger‑Ellison syndrome. Long‑term PPI use is associated with risks such as vitamin B₁₂ deficiency, increased susceptibility to Clostridium difficile infection, and potential kidney damage, so periodic reassessment of continuing need is recommended.

External resource: Proton Pump Inhibitors – StatPearls (NCBI Bookshelf)

Intravenous Fluids and Buffer Systems

Intravenous (IV) fluids must have a pH compatible with blood to prevent phlebitis or tissue damage. Lactated Ringer’s solution, for example, contains lactate, which is metabolized to bicarbonate in the liver, effectively acting as a buffer to correct metabolic acidosis. The lactate is metabolized to bicarbonate via the Cori cycle, yielding a net alkaline effect. Sodium bicarbonate injections are used in emergency settings to treat severe acidosis (e.g., in cardiac arrest or severe metabolic acidosis with pH < 7.1), though their use is carefully controlled due to risks of hypernatremia, hypokalemia, and overshoot alkalosis. Buffer solutions are also essential in parenteral nutrition formulations to maintain amino acid stability and patient safety; typically, these solutions are buffered to a pH around 6.5 to avoid precipitation of calcium phosphate. For fluid resuscitation in hemorrhagic shock, balanced crystalloids (e.g., Plasma‑Lyte) offer a more physiologic pH and electrolyte composition than normal saline, which has a pH of ~5.5 and can contribute to hyperchloremic metabolic acidosis when given in large volumes.

Diagnostic Applications of Acid‑Base Chemistry

Blood Gas Analysis

Arterial blood gas (ABG) analysis remains the gold standard for assessing a patient’s acid‑base status. It directly measures pH, partial pressure of carbon dioxide (pCO₂), and calculates bicarbonate (HCO₃⁻). These values differentiate between respiratory and metabolic components, and help clinicians compute the anion gap to identify unmeasured anions in metabolic acidosis. The delta‑delta ratio (change in anion gap relative to change in bicarbonate) can help detect mixed acid‑base disorders. Venous blood gas (VBG) is a less invasive alternative for monitoring trends, though it may underestimate acidosis. Portable point‑of‑care blood gas analyzers now allow rapid testing in emergency departments and critical care units.

Urinary pH Monitoring

Urinary pH provides insight into renal acid‑base handling and can aid in diagnosing conditions such as renal tubular acidosis, urinary tract infections (e.g., alkaline urine with urease‑producing organisms like Proteus mirabilis), or stone formation. The pH of urine normally ranges from 4.5 to 8.0. Manipulating urinary pH is a key strategy in preventing recurrence of certain kidney stones: for example, alkalinizing the urine with potassium citrate reduces formation of uric acid and cystine stones, while acidifying the urine with ammonium chloride or cranberry juice helps prevent calcium phosphate and struvite stones. Lithotripsy and medical management often incorporate such pH‑guided protocols.

Gastric pH Monitoring

Continuous gastric pH monitoring is used to evaluate the efficacy of acid‑suppressive therapy and to diagnose pathological hypersecretion syndromes, such as Zollinger‑Ellison syndrome (gastrinoma). A gastric pH < 3 suggests inadequate acid suppression, while pH > 5 is targeted for stress ulcer prophylaxis in critically ill patients. It is also employed during enteral feeding to confirm proper tube placement, as a pH < 5 suggests gastric placement, whereas pH > 6 may indicate placement in the small intestine or respiratory tract.

Drug Formulation and Stability

The pH of a drug solution directly affects its chemical stability, solubility, and shelf‑life. Many liquid medications are buffered at an optimal pH to prevent degradation. For instance, amoxicillin suspensions are formulated at a slightly acidic pH (around 5.5) to maintain potency, while morphine sulfate solutions are stabilized with buffers to minimize oxidation. In ophthalmic preparations, pH must be carefully adjusted to between 6.5 and 7.5 to avoid ocular irritation and ensure patient comfort; even small deviations can cause stinging or reflex tearing, reducing drug retention. Injectable drugs must closely match physiological pH (7.4) to reduce injection‑site pain and vascular damage. For example, phenytoin sodium is formulated at pH 12 to maintain solubility, but must be administered slowly with close monitoring due to the risk of venous irritation and purple glove syndrome. Similarly, aminophylline injection has a high pH (8.5–9.5) and can cause phlebitis if infused too rapidly. Buffer selection is a critical part of formulation design; common buffers include citrate, phosphate, and acetate, chosen based on the drug’s pKa and target pH.

Conclusion

Acid‑base chemistry is indispensable across medicine and pharmacology, from the fundamental regulation of blood pH to the rational design of drugs and diagnostic tools. Whether through the use of buffer systems in IV fluids, the pH‑dependent absorption of medications, or the targeted action of antacids and PPIs, a deep understanding of acid‑base equilibria continues to drive therapeutic innovation. Clinicians and researchers who master these principles are better equipped to diagnose disorders, optimize drug therapy, and improve patient outcomes. The continued development of pH‑responsive drug delivery systems and pH‑guided diagnostics promises to further expand the clinical toolbox, making acid‑base chemistry an enduring pillar of modern medicine.